Use of oral corticosteroids and risk of fractures

Journal of Bone and Mineral Research

Volumn 15, Issue 6, 2000, Pages 993-1000

  Van Staa, T P ^a,b   Leufkens, H G M ^b   Abenhaim, L ^c,d   Zhang, B ^a   Cooper, C ^e  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Corticosteroids; Epidemiology; Hip fracture; Osteoporosis

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; ANXIOLYTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CORTICOSTEROID; ESTROGEN; METHOTREXATE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; THIAZIDE DIURETIC AGENT; VITAMIN D;

ADULT; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG INDUCED DISEASE; FEMALE; FRACTURE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PHARMACOEPIDEMIOLOGY; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; STEROID THERAPY; VERTEBRA FRACTURE;

EID: 0034094875     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2000.15.6.993     Document Type: Article

References (0)